Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
CALL
Mohawk Industries
MHK
$8.8B
| $1.13M | ﹤0.01% |
11,000
+2,500
| +29% | +$245K |
|
3877
Spire Global
SPIR
$535M
| $1.13M | ﹤0.01% |
+275,208
| New | +$1.47M |
|
3878
ASE Group
ASX
$98.4B
| $1.13M | ﹤0.01% |
145,352
-2,484,161
| -94% | -$19.1M |
|
3879
Standard BioTools
LAB
$252M
| $1.13M | ﹤0.01% |
586,267
-325,844
| -36% | -$643K |
|
3880
PUT
Vistra
VST
$46B
| $1.13M | ﹤0.01% |
+43,100
| New | +$1.05M |
|
3881
ProShares Bitcoin Strategy ETF
BITO
$1.71B
| $1.13M | ﹤0.01% |
66,600
+3,000
| +5% | +$48.6K |
|
3882
PUT
Global X Lithium & Battery Tech ETF
LIT
$1.63B
| $1.12M | ﹤0.01% |
17,300
+6,500
| +60% | +$405K |
|
3883
Arcus Biosciences
RCUS
$3.72B
| $1.12M | ﹤0.01% |
+55,345
| New | +$1.05M |
|
3884
Renasant Corp
RNST
$3.76B
| $1.12M | ﹤0.01% |
42,915
+26,988
| +169% | +$747K |
|
3885
FLEX LNG
FLNG
$1.7B
| $1.12M | ﹤0.01% |
+36,706
| New | +$1.17M |
|
3886
Viasat
VSAT
$9.28B
| $1.12M | ﹤0.01% |
+27,157
| New | +$1.06M |
|
3887
iShares MSCI Sweden ETF
EWD
$761M
| $1.12M | ﹤0.01% |
31,627
-31,207
| -50% | -$1.12M |
|
|
EGIO
3888
DELISTED
Edgio, Inc. Common Stock
EGIO
| $1.12M | ﹤0.01% |
41,526
+39,378
| +1,833% | +$931K |
|
3889
PUT
Xcel Energy
XEL
$47.8B
| $1.12M | ﹤0.01% |
18,000
+14,900
| +481% | +$995K |
|
3890
Karat Packaging
KRT
$979M
| $1.12M | ﹤0.01% |
61,317
+5,404
| +10% | +$83.4K |
|
3891
Willdan Group
WLDN
$1.34B
| $1.12M | ﹤0.01% |
58,332
+12,827
| +28% | +$216K |
|
3892
CytomX Therapeutics
CTMX
$699M
| $1.12M | ﹤0.01% |
649,298
-311,744
| -32% | -$518K |
|
3893
Triumph Financial Inc
TFIN
$1.72B
| $1.11M | ﹤0.01% |
18,359
-15,711
| -46% | -$863K |
|
|
3894
PUT
Mohawk Industries
MHK
$8.8B
| $1.11M | ﹤0.01% |
10,800
+2,300
| +27% | +$225K |
|
3895
National Health Investors
NHI
$3.54B
| $1.11M | ﹤0.01% |
21,231
-12,945
| -38% | -$667K |
|
3896
Shenandoah Telecom
SHEN
$690M
| $1.11M | ﹤0.01% |
+57,123
| New | +$1.12M |
|
3897
Spyre Therapeutics
SYRE
$7.97B
| $1.11M | ﹤0.01% |
98,129
-51,330
| -34% | -$243K |
|
3898
CALL
GitLab
GTLB
$7.58B
| $1.1M | ﹤0.01% |
+21,600
| New | +$803K |
|
|
FBRT
3899
Franklin BSP Realty Trust
FBRT
$703M
| $1.1M | ﹤0.01% |
+77,961
| New | +$1.03M |
|
|
KRON
3900
DELISTED
Kronos Bio
KRON
| $1.1M | ﹤0.01% |
641,653
-11,916
| -2% | -$18.9K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.